What drugs does CHECKPOINT THERAPEUTICS INC make?

CHECKPOINT THERAPEUTICS INC has 1 FDA-approved drugs.

What therapeutic areas does CHECKPOINT THERAPEUTICS INC focus on?

CHECKPOINT THERAPEUTICS INC focuses primarily on Immunology and Oncology and 1 other therapeutic areas.

← Back

Data updated: Mar 29, 2026

CHECKPOINT THERAPEUTICS INC

ImmunologyOncologyDermatology

Biotech

CHECKPOINT THERAPEUTICS INC is a biotechnology company focused on Immunology, Oncology, Dermatology.

2024

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

UNLOXCYT 2025-11-21

Efficacy

UNLOXCYT 2024-12-13

Type 1 - New Molecular Entity

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 65%

0 drugs Phase 3: 5 Phase 2: 3

Oncology 30%

1 drugs Phase 3: 1 Phase 1: 2

Dermatology 5%

0 drugs Phase 2: 1

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Pfizer big-pharma

Oncology, Dermatology, Immunology

Eli Lilly big-pharma

Oncology, Immunology, Dermatology

COSETTE other

Dermatology, Immunology, Oncology

CHECKPOINT THERAPEUTICS INC

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info

CHECKPOINT THERAPEUTICS INC

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info